| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.877 | 0.004 | 0.884 | Platelet antagonist | 0.884 0.004 CID_15097010 | CID_15097010 | |
| 0.829 | 0.002 | 0.835 | Platelet adhesion inhibitor | 0.835 0.002 CID_15097010 | CID_15097010 | |
| 0.762 | 0.004 | 0.976 | Platelet aggregation inhibitor | 0.976 0.002 CID_15097010 | CID_15097010 | |
| 0.631 | 0.013 | 0.769 | Antithrombotic | 0.769 0.005 CID_15097010 | CID_15097010 | |
| 0.487 | 0.003 | 0.487 | Purinergic P2T antagonist | 0.483 0.003 CID_15097010 | ||
| 0.462 | 0.039 | 0.462 | Thyroid hormone beta antagonist | |||
| 0.456 | 0.041 | 0.456 | Thyroid hormone antagonist | |||
| 0.362 | 0.01 | 0.362 | Hemostatic | 0.311 0.015 CID_15097010 | ||
| 0.298 | 0.018 | 0.298 | Tumour necrosis factor antagonist | 0.224 0.04 CID_15097010 | ||
| 0.234 | 0.005 | 0.234 | Purinergic P2 antagonist | 0.098 0.022 CID_15097010 | ||
| 0.23 | 0.009 | 0.23 | CC chemokine receptor antagonist | 0.187 0.013 CID_15097010 | ||
| 0.203 | 0.018 | 0.203 | Chemokine receptor antagonist | 0.15 0.032 CID_15097010 | ||
| 0.188 | 0.005 | 0.188 | Acetylcholine release stimulant | 0.097 0.095 CID_15097010 | ||
| 0.323 | 0.143 | 0.323 | Cyclophilin D inhibitor | |||
| 0.165 | 0.003 | 0.165 | Glucose-6-phosphate translocase inhibitor | 0.104 0.005 CID_15097010 | ||
| 0.165 | 0.014 | 0.165 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.196 | 0.054 | 0.196 | Thrombolytic | 0.135 0.094 CID_15097010 | ||
| 0.276 | 0.135 | 0.276 | Antiobesity | |||
| 0.145 | 0.01 | 0.145 | Adrenaline uptake inhibitor | 0.066 0.039 CID_15097010 | ||
| 0.115 | 0.008 | 0.115 | Purinergic P2Y antagonist | 0.058 0.02 CID_15097010 | ||
| 0.166 | 0.068 | 0.166 | Anticoagulant | 0.13 0.101 CID_15097010 | ||
| 0.098 | 0.004 | 0.098 | Purinergic P2Y12 antagonist | 0.085 0.004 CID_15097010 | ||
| 0.138 | 0.047 | 0.138 | Papain-like protease (SARS coronavirus) inhibitor | 0.138 0.047 CID_15097010 | ||
| 0.087 | 0.004 | 0.087 | p53 inhibitor | 0.082 0.004 CID_15097010 | ||
| 0.11 | 0.034 | 0.11 | Alpha 2d adrenoreceptor antagonist | |||
| 0.078 | 0.026 | 0.078 | Dopamine uptake inhibitor | |||
| 0.164 | 0.113 | 0.164 | Anticonvulsant | |||
| 0.206 | 0.159 | 0.206 | Cholesterol antagonist | |||
| 0.239 | 0.193 | 0.239 | Analgesic | |||
| 0.051 | 0.007 | 0.051 | Integrin alpha1beta1 antagonist | |||
| 0.083 | 0.044 | 0.083 | Analgesic, opioid | |||
| 0.065 | 0.033 | 0.065 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.135 | 0.104 | 0.135 | Heat shock protein 90 alpha antagonist | |||
| 0.048 | 0.02 | 0.048 | Nerve growth factor antagonist | |||
| 0.054 | 0.036 | 0.083 | Elastase inhibitor | 0.083 0.015 CID_15097010 | CID_15097010 | |
| 0.023 | 0.006 | 0.023 | Microsomal triglyceride transfer protein inhibitor | |||
| 0.042 | 0.026 | 0.042 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.05 | 0.036 | 0.05 | CC chemokine 5 receptor antagonist | |||
| 0.076 | 0.062 | 0.076 | Histamine H1 receptor antagonist | |||
| 0.079 | 0.067 | 0.079 | NMDA receptor antagonist | |||
| 0.025 | 0.013 | 0.025 | Urotensin II antagonist | |||
| 0.101 | 0.089 | 0.101 | Acetylcholine muscarinic antagonist | |||
| 0.095 | 0.086 | 0.095 | DOPA decarboxylase inhibitor | |||
| 0.054 | 0.047 | 0.054 | Protein kinase C iota inhibitor | |||
| 0.185 | 0.184 | 0.185 | 5 Hydroxytryptamine uptake stimulant | 0.185 0.184 CID_15097010 | ||
| 0.042 | 0.041 | 0.042 | GP IIb/IIIa receptor antagonist | |||
| 0.008 | 0.381 | 0.066 | HIV-1 integrase (Strand Transfer) inhibitor | 0.066 0.038 CID_15097010 | CID_15097010 | |
| 0.112 | 0.496 | 0.458 | Antiinflammatory | 0.458 0.106 CID_15097010 | CID_15097010 | |
| 0.006 | 0.48 | 0.058 | HIV-1 integrase (3'-Processing) inhibitor | 0.058 0.049 CID_15097010 | CID_15097010 | |
| 0.03 | 0.623 | 0.08 | Hematopoietic | 0.08 0.074 CID_15097010 | CID_15097010 | |
| 0.018 | 0.783 | 0.31 | Immunosuppressant | 0.31 0.109 CID_15097010 | CID_15097010 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |